Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: A study performed with purified recombinant pollen allergens

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 4, 2000, Pages 803-813

  Aghayan Ugurluoglu, Rousan ^a   Ball, Tanja ^a   Vrtala, Susanne ^a   Schweiger, Christian ^a   Kraft, Dietrich ^a   Valenta, Rudolf ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergen specific IgA and IgE; Allergic conjunctivitis; Mucosal atopy; Recombinant pollen allergens

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; POLLEN EXTRACT;

ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; LACRIMAL FLUID; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; SERUM;

EID: 0034051541     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.104782     Document Type: Article

References (40)

1. 1. Kay AB. Allergy and allergic diseases. Oxford (UK): Blackwell Science; 1997.
2. 2. Ballow M, Mendelson L. Specific immunoglobulin E antibodies in tear secretions of patients with vernal conjunctivitis. J Allergy Clin Immunol 1980;66:112-8.
3. 3. Sompolinsky D, Samra Z, Zavaro A, Barishak Y. Allergen-specific immunoglobulin E antibodies in tears and serum of vernal conjunctivitis patients. Int Arch Allergy Appl Immunol 1984;75:317-21.
4. 4. Hoffmann-Sommergruber K, Ferreira F, Ebner C, Barisani T, Korninger L, Kraft D, et al. Detection of allergen-specific IgE in tears of grass pollen-allergic patients with allergic rhinoconjunctivitis. Clin Exp Allergy 1996;26:79-87.
5. 5. Butrus SI, Ochsner KI, Abelson MB, Schwartz LB. The level of tryptase in human tears: an indicator of activation of conjunctival mast cells. Ophthalmology 1990;97:1678-83.
6. 6. Fujishima H, Takeyama M, Takeuchi T, Saito I, Tsubota K. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy 1997;27:372-8.
7. 7. Montan PG, van Hage-Hamsten M, Zetterstrom O. Sustained cosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge. Clin Exp Allergy 1996;26:1125-30.
8. 8. Ciprandi G, Buscaglia S, Pesce G, Villaggio B, Bagnasco M, Canonica GW. Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993;91:783-92.
9. 9. Bagnasco M, Pesce G, Fiorino N, Riccio AM, Ciprandi G, Buscaglia S, et al. In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammation. Clin Exp Allergy 1997;27:737-43.
10. 10. Metz DP, Bacon AS, Holgate S, Lightman SL. Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease. J Allergy Clin Immunol 1996;98:686-96.
11. 11. Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997;100:817-24.
12. 12. Ballow M, Mendelson L, Donshik P, Rooklin A, Rapacz P. Pollen-specific IgG antibodies in the tears of patients with allergic-like conjunctivitis. J Allergy Clin Immunol 1984;73:376-80.
13. 13. Moller C, Dreborg S, Lanner A, Bjorksten S. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy: a double blind study. Allergy 1986;41:271-9.
14. 14. Taudorf E, Laursen LC, Lanner A, Bjorksten B, Dreborg S, Soborg M, et al. B. Oral immunotherapy in birch pollen bay fever. J Allergy Clin Immunol 1987;80:153-61.
15. 15. Taudorf E, Moller C, Russell MW. Secretory IgA response in oral immunotherapy. Investigation in birch pollinosis. Allergy 1994;49:760-5.
16. 16. Urbanek R, Burgelin KH, Kahle S, Kuhn W, Wahn U. Oral immunotherapy with grass pollen in enterosoluble capsules: a prospective study of the clinical and immunological response. Eur J Pediatr 1990;149:545-50.
17. 17. Valenta R, Kraft D. Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995;7:751-6.
18. 18. Valenta R, Vrtala S, Laffer S, Spitzauer S, Kraft D. Recombinant allergens. Allergy 1998;53:552-61.
19. 19. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H. The recombinant allergen-based concept of componentresolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896-904.
20. 20. Niederberger V, Laffer S, Fröschl R, Kraft D, Rumpold H, Kapiotis S, et al. IgE antibodies to recombinant pollen allergens (Ph1 p 1, Ph1 p 2, Ph1 p 5, Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol 1998;101:258-64.
21. 21. Niederberger V, Pauli G, Grönlund H, Fröschl R, Rumpold H, Kraft D, et al. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel and oak pollen: a quantitative IgE inhibition study with sera from different populations. J Allergy Clin Immunol 1998;102:579-91.
22. 22. Vrtala S, Grote M, Duchene M, VanRee R, Kraft D, Scheiner O, et al. Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenity. Int Arch Allergy Immunol 1993;102:160-69.
23. 23. Lacmmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
24. 24. Bradford MM. A rapid and sensitive method for the quantifiation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
25. 25. Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, et al. Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens. J Allergy Clin Immunol 1996;97:781-7.
26. 26. Laffer S, Valenta R, Vrtala S, Susani M, VanRee R, Kraft D, et al. Complementary DNA cloning of the major allergen Ph1 p 1 from timothy grass (Phleum pratense): recombinant Ph1 p 1 inhibits IgE binding to group 1 allergens from eight different grass species. J Allergy Clin Immunol 1994;94:689-98.
27. 27. Dolecek C, Vrtala S, Laffer S, Steinberger P, Kraft D, Scheiner O, et al. Molecular characterization of Ph1 p 2, a major timothy grass (Phleum pratense) pollen allergen. FEBS Lett 1993;335:299-304.
28. 28. Vrtala S, Sperr WR, Reimitzer I, VanRee R, Laffer S, Müller WD, et al. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen, characterization of the recombinant Ph1 p 5 allergen. J Immunol 1993;151:4773-81.
29. 29. Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Rumpold H, et al. The gene coding for the major birch pollen allergen. Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935-8.
30. 30. Hoffmann-Sommergruber K, Susani M, Ferreira F, Jertschin P, Ahorn H, Steiner R, et al. High-level expression and purification of the major birch pollen allergen, Bet v 1. Protein Expr Purif 1997;9:33-9.
31. 31. Valenta R, Duchene M, Pettenburger K, Sillaber C, Valent P, Bettelheim P, et al. Identification of profilin as a novel pollen allergen: IgE autoreactivity in sensitized individuals. Science 1991;253:557-60.
32. 32. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
33. 33. Bonini S, Bonini S, Vecehione A, Naim DM, Allansmith MR, Balsano F. Inflammatory changes in conjunctival scrapings after allergen provocation in humans. J Allergy Clin Immunol 1988;82:462-9.
34. 34. Sullivan DA. Ocular mucosal immunity. In: Ogra PL, Strober W, Mestecky J, McGhee J, Lamm ME, Bienenstock J, editors. Handbook of mucosal immunology. San Diego: Academic Press; 1994. p 569-97.
35. 35. Garcia-Ortega P, Costa B, Richart C. Evaluation of the conjunctival provocation test in allergy diagnosis. Clin Exp Allergy 1989;19:529-32.
36. 36. Kelly CP, Feighery CF, Gallagher RB, Gibney MJ, Weir DG. Mucosal and systemic IgA anti-gliadin antibody in celiac disease: contrasting patterns of response in serum, saliva, and intestinal secretions. Dig Dis Sci 1991;36:743-51.
37. 37. O'Mahony S, Arranz E, Barton JR, Ferguson A. Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut 1991;32:29-35.
38. 38. Van Ginkel FW, Wahl SM, Kearney JF, Kweon MN, Fujihashi K, Burrows PD, et al. Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice. J Immunol 1999;163:1951-7.
39. 39. Valenta R, Vrtala S, Focke-Tejkl M, Bugajska-Schretter A, Ball T, Twardosz A, et al. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy. Biol Chem 1999;380:815-24.
40. 40. Goodman JS, Van Uden JH, Kobayashi H, Broide D, Raz E. DNA immunotherapeutics: new potential treatment modalities for allergic disease. Int Arch Allergy Immunol 1998;116:177-87.